Jones A G, Francis M D, Davis M A
Semin Nucl Med. 1976 Jan;6(1):3-18. doi: 10.1016/s0001-2998(76)80032-3.
One of the major successes of nuclear medicine in recent years has been the clinical utility of the 99mTc-labeled bone-imaging agents. This article is concerned with the evidence available for the mechanisms by which these and other such radiopharmaceuticals localize at sites in the skeleton.
近年来核医学的主要成功之一是99mTc标记的骨显像剂的临床应用。本文关注的是关于这些以及其他此类放射性药物在骨骼部位定位机制的现有证据。
